Insights

Great Place Cipla USA has been recognized as a Great Place To Work for three consecutive years and is actively hiring across manufacturing, quality control, engineering, and operations, suggesting a stable relationship-building opportunity for supplier and service partnerships with reputable, long-term affiliation.

Growth Hiring Active recruitment alongside interviews indicates potential capacity expansion or modernization initiatives. This creates openings for sales opportunities in equipment, contract manufacturing, quality systems, staffing solutions, and technology upgrades aligned with scaling operations.

Regulatory & Recall History Past recalls and patent-related legal matters point to heightened QA, compliance, and risk management needs. Opportunities exist for sterile manufacturing support, batch traceability systems, quality analytics, recall readiness services, and regulatory intelligence offerings.

US Market Focus As a US-based subsidiary with notable product launches and injections in the portfolio, Cipla USA presents opportunities for US-facing supply chain enhancements, distribution partnerships, packaging optimization, and regional market access initiatives.

Digital & Tech Stack Utilization of cloud and analytics tools (Microsoft Azure, Google Analytics, Tag Manager) signals openness to digital modernization. Potential sales angles include cloud-enabled GMP systems, ERP/SCM integrations, data analytics for forecasting and compliance, and digital marketing/data capture solutions.

Similar companies to CIPLA USA

CIPLA USA Tech Stack

CIPLA USA uses 8 technology products and services including Google Analytics, Drupal, Google Font API, and more. Explore CIPLA USA's tech stack below.

  • Google Analytics
    Analytics
  • Content Management System
  • Google Font API
    Font Scripts
  • jQuery
    Javascript Libraries
  • OWL Carousel
    Javascript Libraries
  • Windows Server
    Operating Systems
  • Platform As A Service
  • Google Tag Manager
    Tag Management

Media & News

CIPLA USA's Email Address Formats

CIPLA USA uses at least 6 email formats:
CIPLA USA Email FormatsExamplePercentage
First.Last@ciplausa.comJohn.Doe@ciplausa.com
67%
FLast@ciplausa.comJDoe@ciplausa.com
33%
First.Last@cipla.comJohn.Doe@cipla.com
84%
F.Last@cipla.comJ.Doe@cipla.com
10%
First@cipla.comJohn@cipla.com
4%
FirstLast@cipla.comJohnDoe@cipla.com
2%

Frequently Asked Questions

What is CIPLA USA's official website and social media links?

Minus sign iconPlus sign icon
CIPLA USA's official website is ciplausa.com and has social profiles on LinkedIn.

How much revenue does CIPLA USA generate?

Minus sign iconPlus sign icon
As of October 2026, CIPLA USA's annual revenue is estimated to be $10M - $25M.

What is CIPLA USA's NAICS code?

Minus sign iconPlus sign icon
CIPLA USA's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does CIPLA USA have currently?

Minus sign iconPlus sign icon
As of October 2026, CIPLA USA has approximately 81 employees across 2 continents, including North America and Asia. Key team members include Manufacturing Manager: M. P., Principal: E. M. and Senior Chargeback Analyst: S. B. Explore CIPLA USA's employee directory with LeadIQ.

What industry does CIPLA USA belong to?

Minus sign iconPlus sign icon
CIPLA USA operates in the Pharmaceuticals industry.

What technology does CIPLA USA use?

Minus sign iconPlus sign icon
CIPLA USA's tech stack includes Google Analytics, Drupal, Google Font API, jQuery, OWL Carousel, Windows Server, Microsoft Azure and Google Tag Manager.

What is CIPLA USA's email format?

Minus sign iconPlus sign icon
CIPLA USA's email format typically follows the pattern of First.Last@ciplausa.com. Find more CIPLA USA email formats with LeadIQ.
CIPLA USA logo

CIPLA USA

PharmaceuticalsFlorida, United States51-200 Employees

CIPLA USA is a pharmaceutical manufacturing company based in Miami, Florida, focused on producing medicines for the U.S. market. The business maintains operations across manufacturing, quality control, engineering, and general operations, reflecting its production-centric role in the sector. It is a mid-sized producer in the pharmaceutical manufacturing sector, with facilities and functions that cover core production disciplines.

The company's product history includes the launch of Leuprolide Acetate Injection Depot 22.5 mg in 2022 and Daptomycin for Injection in 2019, illustrating its involvement in injectable therapies for the U.S. market. It has faced quality and regulatory events, such as a 2021 recall of six batches of Albuterol Sulfate inhalation Aerosol (90 mcg), disclosed in later reporting. More recently, CIPLA USA has been recognized as a Great Place To Work in 2023 and again in 2025, and it is actively recruiting for roles across manufacturing, quality control, engineering, and operations.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
51-200

Section iconFunding & Financials

  • $10M - $25M

    CIPLA USA's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.